TRIM50 acts as a novel Src suppressor and inhibits ovarian cancer progression-Reference-Cited by-同舟云学术

TRIM50 acts as a novel Src suppressor and inhibits ovarian cancer progression

Published:2019-09 Issue:9 Volume:1866 Page:1412-1420
ISSN:0167-4889
Container-title:Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Molecular Cell Research

Author:

Qiu Yumin,Liu Peishu,Ma Xiaomin,Ma Xiaoxiao,Zhu Lihui,Lin Yueke,You Yajing,Yu Wenhao,Ma Dapeng,Sun Caiyu,Qin Zhenzhi,Zhao Yunxue,Shi Juanjuan,Han Lihui

Funder

National Natural Science Foundation of China

Major Innovation Project of Shandong Province

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology

Reference22 articles.

1. Hyperthermic intraperitoneal chemotherapy in ovarian cancer;van Driel;N. Engl. J. Med.,2018

2. Dual Src and MEK inhibition decreases ovarian cancer growth and targets tumor initiating stem-like cells;Simpkins;Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res.,2018

3. Regulation of SRC family kinases in human cancers;Sen;J. Sig. Transduct.,2011

4. Src activation by beta-adrenoreceptors is a key switch for tumour metastasis;Armaiz-Pena;Nat. Commun.,2013

5. Phase II evaluation of dasatinib in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: a gynecologic oncology group study;Schilder;Gynecol. Oncol.,2012

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An investigation of the molecular characterization of the tripartite motif (TRIM) family and primary validation of TRIM31 in gastric cancer;Human Genomics;2024-07-09

2. Emerging roles of tripartite motif family proteins (TRIMs) in breast cancer;Cancer Medicine;2024-07

3. MiRNAs: Emerging Agents for Therapeutic Effects of Polyphenols on Ovarian Cancer;Mini-Reviews in Medicinal Chemistry;2024-03

4. Tripartite motif family – its role in tumor progression and therapy resistance: a review;Current Opinion in Oncology;2024-01-16

5. TRIM50 inhibits glycolysis and the malignant progression of gastric cancer by ubiquitinating PGK1;International Journal of Biological Sciences;2024